CAMBRIDGE, Mass., Oct. 13, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. ET on Thursday, October 27 to provide a business update and discuss its third-quarter 2011 financial and operational results.
